Agnieszka Boesen

Array ( [id] => 4859686 [patent_doc_number] => 20080268536 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-30 [patent_title] => 'Humanized Anti-CCR2 Antibodies and Methods of Use Therefor' [patent_app_type] => utility [patent_app_number] => 11/924091 [patent_app_country] => US [patent_app_date] => 2007-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 33505 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0268/20080268536.pdf [firstpage_image] =>[orig_patent_app_number] => 11924091 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4719400 [patent_doc_number] => 20080241923 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-02 [patent_title] => 'Humanized Anti-CCR2 Antibodies and Methods of Use Therefor' [patent_app_type] => utility [patent_app_number] => 11/924153 [patent_app_country] => US [patent_app_date] => 2007-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 33494 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0241/20080241923.pdf [firstpage_image] =>[orig_patent_app_number] => 11924153 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5284853 [patent_doc_number] => 20090098528 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-16 [patent_title] => 'Method for determining early HCV seroconversion' [patent_app_type] => utility [patent_app_number] => 11/974030 [patent_app_country] => US [patent_app_date] => 2007-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5100 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20090098528.pdf [firstpage_image] =>[orig_patent_app_number] => 11974030 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5585021 [patent_doc_number] => 20090104223 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-23 [patent_title] => 'Method for Obtaining Antigenic Aggregates and the Use Thereof in Formulations' [patent_app_type] => utility [patent_app_number] => 11/870088 [patent_app_country] => US [patent_app_date] => 2007-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 4618 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20090104223.pdf [firstpage_image] =>[orig_patent_app_number] => 11870088 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4778850 [patent_doc_number] => 20080286848 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-20 [patent_title] => 'RECOVERY OF RECOMBINANT HUMAN PARAINFLUENZA VIRUS TYPE 2 (HPIV2) FROM cDNA AND USE OF RECOMBINANT HPIV2 IN IMMUNOGENIC COMPOSITIONS AND AS VECTORS TO ELICIT IMMUNE RESPONSES AGAINST PIV AND OTHER HUMAN PATHOGENS' [patent_app_type] => utility [patent_app_number] => 11/864120 [patent_app_country] => US [patent_app_date] => 2007-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 60969 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20080286848.pdf [firstpage_image] =>[orig_patent_app_number] => 11864120 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8617718 [patent_doc_number] => 20130023030 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2013-01-24 [patent_title] => 'RECOVERY OF RECOMBINANT HUMAN PARAINFLUENZA VIRUS TYPE 2 (HYPIV2) FROM CDNA AND USE OF RECOMBINANT HPIV2 IN IMMUNOGENIC COMPOSITIONS AND AS VECTORS TO ELICIT IMMUNE RESPONSES AGAINST PIV AND OTHER HUMAN PATHOGENS' [patent_app_type] => utility [patent_app_number] => 11/863196 [patent_app_country] => US [patent_app_date] => 2007-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 60970 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11863196 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8617718 [patent_doc_number] => 20130023030 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2013-01-24 [patent_title] => 'RECOVERY OF RECOMBINANT HUMAN PARAINFLUENZA VIRUS TYPE 2 (HYPIV2) FROM CDNA AND USE OF RECOMBINANT HPIV2 IN IMMUNOGENIC COMPOSITIONS AND AS VECTORS TO ELICIT IMMUNE RESPONSES AGAINST PIV AND OTHER HUMAN PATHOGENS' [patent_app_type] => utility [patent_app_number] => 11/863196 [patent_app_country] => US [patent_app_date] => 2007-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 60970 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11863196 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4938374 [patent_doc_number] => 20080075693 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-27 [patent_title] => 'METHODS FOR TREATING VIRAL INFECTION USING IL-28 AND IL-29 CYSTEINE MUTANTS' [patent_app_type] => utility [patent_app_number] => 11/858699 [patent_app_country] => US [patent_app_date] => 2007-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39388 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0075/20080075693.pdf [firstpage_image] =>[orig_patent_app_number] => 11858699 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4903561 [patent_doc_number] => 20080112974 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-15 [patent_title] => 'METHOD FOR INDUCING MUCOSAL HUMORAL AND CELL-MEDIATED IMMUNE RESPONSES BY SUBLINGUAL ADMINISTRATION OF ANTIGENS' [patent_app_type] => utility [patent_app_number] => 11/851998 [patent_app_country] => US [patent_app_date] => 2007-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 11578 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20080112974.pdf [firstpage_image] =>[orig_patent_app_number] => 11851998 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7712707 [patent_doc_number] => 08093353 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-10 [patent_title] => 'Agents for treatment of HCV and methods of use' [patent_app_type] => utility [patent_app_number] => 11/899393 [patent_app_country] => US [patent_app_date] => 2007-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 25 [patent_no_of_words] => 16935 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/093/08093353.pdf [firstpage_image] =>[orig_patent_app_number] => 11899393 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 363340 [patent_doc_number] => 07482150 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-01-27 [patent_title] => 'Virulent systemic feline calicivirus' [patent_app_type] => utility [patent_app_number] => 11/849164 [patent_app_country] => US [patent_app_date] => 2007-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 1 [patent_no_of_words] => 11740 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/482/07482150.pdf [firstpage_image] =>[orig_patent_app_number] => 11849164 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4846487 [patent_doc_number] => 20080182895 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-31 [patent_title] => 'IDENTIFICATION AND CHARACTERIZATION OF HCV REPLICON VARIANTS WITH REDUCED SUSCEPTIBILITY TO HCV-796, AND METHODS RELATED THERETO' [patent_app_type] => utility [patent_app_number] => 11/842312 [patent_app_country] => US [patent_app_date] => 2007-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 26302 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20080182895.pdf [firstpage_image] =>[orig_patent_app_number] => 11842312 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9026086 [patent_doc_number] => 08535665 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-09-17 [patent_title] => 'Process for identification of molecular mimicry and the uses thereof' [patent_app_type] => utility [patent_app_number] => 12/310174 [patent_app_country] => US [patent_app_date] => 2007-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 13643 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 143 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12310174 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4719395 [patent_doc_number] => 20080241918 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-02 [patent_title] => 'Hemagglutinin polypeptides, and reagents and methods relating thereto' [patent_app_type] => utility [patent_app_number] => 11/893171 [patent_app_country] => US [patent_app_date] => 2007-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 39 [patent_no_of_words] => 27206 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0241/20080241918.pdf [firstpage_image] =>[orig_patent_app_number] => 11893171 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6615423 [patent_doc_number] => 20100310553 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-09 [patent_title] => 'Compositions and Methods for Controlling Hepatitis C Virus Infection' [patent_app_type] => utility [patent_app_number] => 12/438137 [patent_app_country] => US [patent_app_date] => 2007-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 8150 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0310/20100310553.pdf [firstpage_image] =>[orig_patent_app_number] => 12438137 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9355046 [patent_doc_number] => 08673579 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-03-18 [patent_title] => 'Peptide probes for diagnostics and therapeutics' [patent_app_type] => utility [patent_app_number] => 11/828953 [patent_app_country] => US [patent_app_date] => 2007-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 15 [patent_no_of_words] => 36659 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 150 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11828953 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4807424 [patent_doc_number] => 20080171002 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-17 [patent_title] => 'Products For Receptor Mediated Activation And Maturation Of Monocyte-Derived Dendritic Cells By A Phosphorylated Glucomannane Polysaccharide' [patent_app_type] => utility [patent_app_number] => 11/781135 [patent_app_country] => US [patent_app_date] => 2007-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 14500 [patent_no_of_claims] => 118 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20080171002.pdf [firstpage_image] =>[orig_patent_app_number] => 11781135 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6577400 [patent_doc_number] => 20100047277 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-25 [patent_title] => 'VIROSOMES, METHODS OF PREPARATION, AND IMMUNOGENIC COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 12/373595 [patent_app_country] => US [patent_app_date] => 2007-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 24069 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0047/20100047277.pdf [firstpage_image] =>[orig_patent_app_number] => 12373595 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6593674 [patent_doc_number] => 20100048470 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-25 [patent_title] => 'IMMUNOTOXINS FOR THE TREATMENT OF DISEASES RELATED TO CMV INFECTION' [patent_app_type] => utility [patent_app_number] => 12/306395 [patent_app_country] => US [patent_app_date] => 2007-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24266 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20100048470.pdf [firstpage_image] =>[orig_patent_app_number] => 12306395 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5264470 [patent_doc_number] => 20090117155 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-07 [patent_title] => 'TREATMENT OF HIV-1 BY MODULATION OF VPR ACTIVATION OF THE M-CSF PROMOTER' [patent_app_type] => utility [patent_app_number] => 12/302189 [patent_app_country] => US [patent_app_date] => 2007-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 16420 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0117/20090117155.pdf [firstpage_image] =>[orig_patent_app_number] => 12302189 [rel_patent_id] =>[rel_patent_doc_number] =>)